Register for our free email digests:
Fluidigm Corp.
www.fluidigm.com
Latest From Fluidigm Corp.
Execs On The Move, December 2016
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Execs On The Move, September 2016
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Medical Device Deals Update, September 2015
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced July-August 2015.
Diagnostics In 2014: More Of The Same
In many ways, the year in diagnostics can be characterized as “more of the same.” The biggest newsmaker was FDA’s finally taking steps toward establishing an oversight framework for the regulation of laboratory-developed tests.
Company Information
- Industry
-
Biotechnology
- Nanotechnology, Chips, etc.
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
- Therapeutic Areas
- Non-Specific
- Alias(es)
- Mycometrix Corp.
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Fluidigm Corp.
- Senior Management
-
S. Christopher Linthwaite, Pres. & CEO
Vikram Jog, CFO
Colin McCracken, Chief Commercial Officer
Andrew Quong, PhD, CSO - Contact Info
-
Fluidigm Corp.
Phone: (650) 266-6000
7000 Shoreline Ct.
Ste. 100
South San Francisco, CA 94080
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice